RMD-mILDer: Home based clinical management of Interstitial Lung Disease (ILD) in systemic rheumatic conditions; the Nor-mILDeR randomized strategy trial, including also Romania and Switzerland as participating countries. Included 91 patients in December 2025.
The Nor-SSCardioCare pilot study: Home-based clinical management of PAH in systemic sclerosis patients of 12 patients from March-June 2025.
I-FILE study – international multicentre home spirometry study in fibrotic interstitial lung diseases. Included 20 patients.
68Ga-DOTATOC PET/CT uptake in systemic sclerosis: a prospective, single-centre pilot study. 8 patients included in 2025
CONQUEST: Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani Bet al.(2026) ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease Eur Respir J, 67(1) DOI 10.1183/13993003.02533-2024, PubMed 40907995
Balbi M, Ledda RE, Mura R, Poletti V, Hoffmann-Vold AM, Prosch H, Sverzellati N(2026) Critical dialogue: Interstitial lung abnormalities: an evolving concept Insights Imaging, 17(1) DOI 10.1186/s13244-026-02357-7, PubMed 42557518
Bendstrup E, Dieude P, Kreuter M, Hoffmann-Vold AM, Cottin V, Hauge EM(2026) Lung disease in rheumatoid arthritis Nat Rev Rheumatol, 22(9), 558-570 DOI 10.1038/s41584-026-01394-2, PubMed 42315602
